INDIAN MARKET

INTERNATIONAL BUSINESS

Audited Financial Results for the Year ended 31st March, 2008

(Rs. In Lacs)

Sr. No. Particulars Quarter ended  31.03.2008 (Audited) Quarter ended  31.03.2007 (Unaudited) Year ended  31.03.2008 (Audited) Year ended 31.03.2007 (Audited)   
1 Net Sales / Income from Operations 3415.96 3258.52 12594.22 12840.07
2 Other income 34.51 10.40 40.96 22.96
3 Total (1+2) 3450.47 3268.92 12635.18 12863.03
4 Expenditure        
  a)  (Increase) / Decrease in Stock-in-Trade & Work in Progress 63.62 353.83 205.12 (85.28)
  b)  Consumption of Raw Materials 2843.17 1820.32 8984.59 8364.74
  c)  Employee Cost 410.91 410.15 1608.77 1519.87
  d) Depreciation and Amortisation 1062.95 1229.46 4709.40 4905.80
  e)  Other Expenditure 35.15 579.00 2369.96 2449.85
  Total  4415.80 4392.76 17877.84 17154.98
5 Interest  4.14 89.61 926.73 528.31
6 Exceptional Items                            -                              -                              -                              -  
7 Profit / (Loss) from Ordinary Activities before Tax (3) - (4+5+6) (969.47) (1213.45) (6169.39) (4820.26)
8 Tax Expense                            
  - Fringe Benefit Tax 4.59 14.98 21.06 22.55
  - Deffered Tax Assets                            -                              -                              -   2444.49
9 Profit / (Loss) from Ordinary Activities after Tax (7-8) (974.06) (1228.43) (6190.45) (7287.30)
10 Extraordinary Items-Income/(Expense)                   898.10                            -                  1,313.88 (8474.80)
11 Net Profit /(Loss)  (9-10) (75.96) (1228.43) (4876.57) (15762.10)
12 Paid-up Equity Share Capital of Face Value of Rs.2/- each 7141.75 4220.80 7141.75 4220.80
13 Reserves excluding revaluation reserves     60240.97 43907.72
14 (a) Earning Per Share before Extraordinary Items (in Rs.) -                        
  Basic & Diluted (0.27) (0.58) (2.47) (3.45)
(b) Earning Per Share after Extraordinary Items (in Rs.) -                                           
  Basic & Diluted (0.02) (0.58) (1.92) (7.50)
15 Public Shareholding        
  Number of Shares 201964202 140708412 201964202 140708412
   Percentage of shareholding 56.52% 66.67% 56.52% 66.67%

Notes:

  1. The above results have been audited by Statutory Auditors of the company and approved by Board of Directors at its meeting  held on 15th May, 2008 
  2. The Company is exclusively engaged in the Pharmaceutical Business segment. Capital employed as on 31st March, 2008 is Rs.64415.09 Lacs.
  3. Pending adjudication of petition filed  u/s 391 of Companies Act, 1956  before Hon'ble  High Court of Himachal Pradesh at Shimla  interest of  Rs. 1029.37 Lacs is not  provided during the year. 
  4. Extraordinary items of Rs. 1313.88 Lacs represents net of incomes in respect of waiver received from Banks/Institutions, currency fluctuation/expenses related to GDR and  interest written back.
  5. Consolidated Sales, Profit(Loss) after tax and EPS for the year ended March 31, 2008 stands at Rs. 14776.71 Lacs ,  Rs.(-) 5485.83 Lacs & Rs.(-)2.16.
  6. During the last Quarter, 4 shareholders' complaint were received  which have been attended/redressed.
   
Place: New Delhi
Date: 15.05.2008
(Sushil Suri)
Chairman & Managing Director